SYK
NYSE · Health Care
Stryker Corp
$275.31
+2.95 (+1.08%)
Financial Highlights (FY 2026)
Revenue
25.11B
Net Income
3.24B
Gross Margin
64.6%
Profit Margin
12.9%
Rev Growth
+10.8%
D/E Ratio
0.71
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 64.6% | 64.6% | 44.1% | 44.1% |
| Operating Margin | 19.4% | 17.4% | 16.2% | 16.0% |
| Profit Margin | 12.9% | 12.3% | 18.9% | 14.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 25.11B | 22.65B | 43.49B | 43.47B |
| Gross Profit | 16.21B | 14.63B | 19.17B | 19.16B |
| Operating Income | 4.86B | 3.95B | 7.07B | 6.94B |
| Net Income | 3.24B | 2.63B | 8.24B | 6.44B |
| Gross Margin | 64.6% | 64.6% | 44.1% | 44.1% |
| Operating Margin | 19.4% | 17.4% | 16.2% | 16.0% |
| Profit Margin | 12.9% | 12.3% | 18.9% | 14.8% |
| Rev Growth | +10.8% | +10.8% | +22.5% | +13.0% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 21.80B | 21.80B | 32.34B | 34.71B |
| Total Equity | 30.82B | 30.82B | 61.80B | 69.01B |
| D/E Ratio | 0.71 | 0.71 | 0.52 | 0.50 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 5.59B | 4.79B | 9.81B | 9.91B |
| Free Cash Flow | — | — | 3.51B | 3.84B |